Wikidata entity: Q420383
C₁₂H₁₄N₂O₂ (P274)
Quantities
| P4250 | defined daily dose | 1.25 |
| P2067 | mass | 218.105528 |
| P3780 | active ingredient in | ... | Q47521863 (Mysoline) | Mysoline |
| P233 | canonical SMILES | String | CCC1(C(=O)NCNC1=O)C2=CC=CC=C2 | ??? |
| P373 | Commons category | String | Primidone | ??? |
| P366 | has use | ... | Q12140 (medication) | medication |
| P31 | instance of | ... | Q113145171 (type of chemical entity) | type of chemical entity |
| P2175 | medical condition treated | ... | Q41571 (epilepsy) | epilepsy |
| P2175 | medical condition treated | ... | Q223907 (tremor) | tremor |
| P3489 | pregnancy category | ... | Q28123618 (US pregnancy category D) | US pregnancy category D |
| P769 | significant drug interaction | ... | Q174723 (codeine) | codeine |
| P769 | significant drug interaction | ... | Q58614 (loxapine) | loxapine |
| P769 | significant drug interaction | ... | Q81225 (morphine) | morphine |
| P769 | significant drug interaction | ... | Q55434 (pethidine) | pethidine |
| P769 | significant drug interaction | ... | Q176533 (alfentanil) | alfentanil |
| P769 | significant drug interaction | ... | Q178566 (chlordiazepoxide) | chlordiazepoxide |
| P769 | significant drug interaction | ... | Q179996 ((RS)-methadone) | (RS)-methadone |
| P769 | significant drug interaction | ... | Q186257 (lormetazepam) | lormetazepam |
| P769 | significant drug interaction | ... | Q210402 (diazepam) | diazepam |
| P769 | significant drug interaction | ... | Q303646 (hydromorphone) | hydromorphone |
| P769 | significant drug interaction | ... | Q319877 (alprazolam) | alprazolam |
| P769 | significant drug interaction | ... | Q407541 (fentanyl) | fentanyl |
| P769 | significant drug interaction | ... | Q377270 (dihydrocodeine) | dihydrocodeine |
| P769 | significant drug interaction | ... | Q407241 (phenobarbital) | phenobarbital |
| P769 | significant drug interaction | ... | Q407535 (oxycodone) | oxycodone |
| P769 | significant drug interaction | ... | Q407592 (tramadol) | tramadol |
| P769 | significant drug interaction | ... | Q407721 (buprenorphine) | buprenorphine |
| P769 | significant drug interaction | ... | Q407988 (clonazepam) | clonazepam |
| P769 | significant drug interaction | ... | Q408265 (lorazepam) | lorazepam |
| P769 | significant drug interaction | ... | Q113368879 (rac-warfarin) | rac-warfarin |
| P769 | significant drug interaction | ... | Q410078 (nitrazepam) | nitrazepam |
| P769 | significant drug interaction | ... | Q412164 (clobazam) | clobazam |
| P769 | significant drug interaction | ... | Q412299 (oxazepam) | oxazepam |
| P769 | significant drug interaction | ... | Q418998 (flurazepam) | flurazepam |
| P769 | significant drug interaction | ... | Q414463 (tapentadol) | tapentadol |
| P769 | significant drug interaction | ... | Q417915 (sufentanil) | sufentanil |
| P769 | significant drug interaction | ... | Q418656 (procarbazine) | procarbazine |
| P769 | significant drug interaction | ... | Q2622907 (periciazine) | periciazine |
| P769 | significant drug interaction | ... | Q7553347 (sodium oxybate) | sodium oxybate |
| P279 | subclass of | ... | Q11173 (chemical compound) | chemical compound |
| P2868 | subject has role | ... | Q187661 (carcinogen) | carcinogen |
| P2868 | subject has role | ... | Q576618 (anticonvulsant agent) | anticonvulsant agent |
| P2275 | World Health Organisation international non-proprietary name | Monolingualtext | primidone | ??? |
Why not click here or view trends?
log id: 2107921